Publications (130) ANDRÉS ÍÑIGUEZ ROMO publications

2023

  1. Changes in circulating ApoJ-Glyc levels in patients with suspected acute coronary syndrome: The EDICA trial

    International Journal of Cardiology, Vol. 391

  2. Impact of Age at the Time of the First ST-Elevation Myocardial Infarction on 10-Year Outcomes (from the EXAMINATION-EXTEND Trial)

    American Journal of Cardiology, Vol. 190, pp. 32-40

  3. Trends in cardiovascular care in the National Health System in Spain. Data from the RECALCAR project 2011-2020

    Revista Espanola de Cardiologia, Vol. 76, Núm. 7, pp. 519-530

2022

  1. A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction

    Circulation, Vol. 146, Núm. 16, pp. 1196-1206

  2. Angiography-derived physiology guidance vs usual care in an All-comers PCI population treated with the healing-targeted supreme stent and Ticagrelor monotherapy: PIONEER IV trial design

    American Heart Journal, Vol. 246, pp. 32-43

  3. Avances tecnológicos en el tratamiento de las enfermedades cardiovasculares: perspectiva de médicos y administradores

    REC: Interventional Cardiology, Vol. 4, Núm. 3, pp. 243-245

  4. Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: Final results of the SYNTAX II study

    European Heart Journal, Vol. 43, Núm. 13, pp. 1307-1316

  5. Impact of Diabetes on 10-Year Outcomes Following ST-Segment–Elevation Myocardial Infarction: Insights From the EXAMINATION-EXTEND Trial

    Journal of the American Heart Association, Vol. 11, Núm. 23

  6. Sex Differences in 10-Year Outcomes Following STEMI: A Subanalysis From the EXAMINATION-EXTEND Trial

    JACC: Cardiovascular Interventions, Vol. 15, Núm. 19, pp. 1965-1973

2021

  1. Percutaneous and surgical aortic valve replacement. Impact of volume and type of center on results

    REC: Interventional Cardiology, Vol. 3, Núm. 2, pp. 103-111

  2. Reemplazo valvular aórtico percutáneo y quirúrgico.: Influencia del volumen y del tipo de centro tratante en los resultados

    REC: Interventional Cardiology, Vol. 3, Núm. 2, pp. 103-111

  3. TAVI en la curva de aprendizaje en España. Resultados intrahospitalarios comparados con la sustitución valvular aórtica

    REC: CardioClinics, Vol. 56, Núm. 4, pp. 242-249

  4. TAVI in the learning curve in Spain. In-hospital results compared with aortic valve replacement

    REC: CardioClinics, Vol. 56, Núm. 4, pp. 242-249

  5. Triglycerides and Residual Atherosclerotic Risk

    Journal of the American College of Cardiology, Vol. 77, Núm. 24, pp. 3031-3041

2020

  1. Second-Generation Drug-Eluting Stents in Diabetes (SUGAR) trial: Rationale and study design

    American Heart Journal, Vol. 222, pp. 174-182

2019

  1. Clinical and Administrative Data on the Research of Acute Coronary Syndrome in Spain. Minimum Basic Data Set Validity

    Revista Espanola de Cardiologia, Vol. 72, Núm. 1, pp. 56-62

  2. Clinical outcomes of state-of-the-art percutaneous coronary revascularisation in patients with three-vessel disease: Twoyear follow-up of the SYNTAX II study

    EuroIntervention, Vol. 15, Núm. 3, pp. E244-A252

  3. Long-term impact of diabetes in patients with ST-segment elevation myocardial infarction: Insights from the EXAMINATION randomized trial

    Catheterization and Cardiovascular Interventions, Vol. 94, Núm. 7, pp. 917-925

  4. Management of myocardial infarction in the elderly. Insights from Spanish Minimum Basic Data Set

    European Heart Journal: Acute Cardiovascular Care, Vol. 8, Núm. 3, pp. 242-251

  5. Requisitos y sostenibilidad de los programas de ICP primaria en España en el IAMCEST.: Documento de consenso de SEC, AEEC y SEMES

    REC: Interventional Cardiology, Vol. 1, Núm. 2, pp. 108-119